Options Play of the Week: A Mid-Cap Biopharma in the Crosshairs

view original post

My options play this week centers around a midcap biopharma I have had a series of successful covered call trades on over the past few yearsThe stock is Acadia Pharmaceuticals (ACAD) , which trades just above $19.00 a share and has a market capitalization slightly north of $3 billionAcadia has one product on the market called NuplazidThis compound…

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a subscriber? Please Login